Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases-Reference-Cited by-同舟云学术

Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases

Published:1990-06 Issue:2 Volume:161 Page:153-160
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Lowe James,McDermott Helen,Landon Michael,Mayer R. John,Wilkinson Keith D.

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference26 articles.

1. Ubiquitin Is a Component of Paired Helical Filaments in Alzheimer's Disease

2. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.

3. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease

4. A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin

5. Ubiquitin deposits in anterior horn cells in motor neurone disease

Cited by 330 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease;Future Pharmacology;2024-04-30

2. Recent advances in the development of deubiquitinases inhibitors as antitumor agents;European Journal of Medicinal Chemistry;2024-02

3. Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson’s Disease;International Journal of Molecular Sciences;2024-01-21

4. Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease;Frontiers in Neurology;2023-09-28

5. Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions;Translational Neurodegeneration;2023-07-19